Volume 24 Issue 4
Apr.  2026
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2026  >  24(4): 544-558
General Practice Branch of Cross-Straits Medicine Exchange Association, General Practice Branch of Zhejiang Medical Association, Medically Unspecified Disease Professional Committee of Zhejiang Society for Mathematical Medicine, the Expert Collaboration Group on Medically Unspecified Disease in General Practice, Chinese Geriatrics Society. Expert consensus on the diagnosis, treatment, and management of hyperhidrosis (2025)[J]. Chinese Journal of General Practice, 2026, 24(4): 544-558. doi: 10.16766/j.cnki.issn.1674-4152.004438
Citation: General Practice Branch of Cross-Straits Medicine Exchange Association, General Practice Branch of Zhejiang Medical Association, Medically Unspecified Disease Professional Committee of Zhejiang Society for Mathematical Medicine, the Expert Collaboration Group on Medically Unspecified Disease in General Practice, Chinese Geriatrics Society. Expert consensus on the diagnosis, treatment, and management of hyperhidrosis (2025)[J]. Chinese Journal of General Practice, 2026, 24(4): 544-558. doi: 10.16766/j.cnki.issn.1674-4152.004438
shu

Expert consensus on the diagnosis, treatment, and management of hyperhidrosis (2025)

doi: 10.16766/j.cnki.issn.1674-4152.004438
Funds:

 72274169

  • Received Date: 2025-12-23
    Abstract
  • Hyperhidrosis is a common clinical manifestation that may occur independently or as a concomitant symptom of systemic diseases, significantly impacting an individual's daily life, work, social interactions, and psychological well-being. Currently, China lacks large-scale epidemiological data on hyperhidrosis, and there is no unified diagnostic criteria or severity grading system, leading to inconsistent clinical judgments for the same condition. This consensus, oriented towards the diagnosis, treatment, and management of hyperhidrosis, systematically elaborates on its definition, epidemiological characteristics, etiology, and pathogenesis. It reviews diagnostic methods, including detailed history taking, physical examination, assessment tools, and diagnostic procedures, and provides a detailed exposition of treatment principles, protocols, and interventions. Furthermore, this consensus proposes recommendations for the comprehensive management of hyperhidrosis, covering community management, follow-up, bidirectional referral, health education, and future research directions. The aim is to provide standardized and normalized guidance for general practitioners and relevant medical professionals, thereby improving the accuracy of etiological diagnosis, optimizing treatment outcomes, and enhancing patients'quality of life.

     

    • FullText(HTML)
  • loading
    • References(89)
  • [1]
    LAKRAJ A A, MOGHIMI N, JABBARI B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins[J]. Toxins (Basel), 2013, 5(4): 821-840. doi: 10.3390/toxins5040821
    [2]
    李玲玲, 曲天歌, 段行武, 等. 原发性多汗症的中西医理论辨析[J]. 现代中医临床, 2019, 26(3): 45-49.
    [3]
    黎恒, 吴松. 原发性多汗症[J]. 临床皮肤科杂志, 2025, 54(6): 374-378.
    [4]
    MONIATI F, VASSILIOU M, COSTA C, et al. Efficacy and safety of treatments for primary palmar hyperhidrosis: a systematic review assessing patient-centric outcomes[J]. Dermatol Res Pract, 2025, 2025: 8867838. DOI: 10.1155/drp/8867838.
    [5]
    涂远荣, 刘彦国. 中国手汗症微创治疗临床指南(2021年版)[J]. 中国胸心血管外科临床杂志, 2021, 28(10): 1133-1139.
    [6]
    孙秋宁, 房柔妤, 陈典. 多汗症及腋臭的肉毒素注射治疗专家共识[J]. 中国中西医结合皮肤性病学杂志, 2017, 16(1): 90-93.
    [7]
    GORELICK J, FRIEDMAN A. Diagnosis and management of primary hyperhidrosis: practical guidance and current therapy update[J]. J Drugs Dermatol, 2020, 19(7): 704-710. doi: 10.36849/JDD.2020.5162
    [8]
    SOLISH N, BERTUCCI V, DANSEREAU A, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee[J]. Dermatol Surg, 2007, 33(8): 908-923.
    [9]
    LIU Y, WENG W, TU Y, et al. Chinese Expert Committee on Palmar Hyperhidrosis. Chinese expert consensus on the surgical treatment of primary palmar hyperhidrosis (2021 version)[J]. Chin Med J (Engl), 2022, 135(11): 1264-1271. doi: 10.1097/CM9.0000000000002198
    [10]
    DOOLITTLE J, WALKER P, MILLS T, et al. Hyperhidrosis: an update on prevalence and severity in the United States[J]. Arch Dermatol Res, 2016, 308(10): 743-749. doi: 10.1007/s00403-016-1697-9
    [11]
    LIU Y, BAHAR R, KALIA S, et al. Hyperhidrosis prevalence and demographical characteristics in dermatology outpatients in Shanghai and Vancouver[J]. PLoS One, 2016, 11(4): e0153719. DOI: 10.1371/journal.pone.0153719.
    [12]
    WOHLRAB J, BECHARA F G, SCHICK C, et al. Hyperhidrosis: a central nervous dysfunction of sweat secretion[J]. Dermatol Ther (Heidelb), 2023, 13(2): 453-463. doi: 10.1007/s13555-022-00885-w
    [13]
    NASTASE F, VERENCA M C, NICULET E, et al. Primary hyperhidrosis in children-a retrospective study and a short review[J]. Life (Basel), 2024, 14(5): 645. DOI: 10.3390/life14050645.
    [14]
    MAAZI M, LEUNG A K, LAM J M. Primary hyperhidrosis: an updated review[J]. Drugs Context, 2025, 14: 2025-3-2. DOI: 10.7573/dic.2025-3-2.
    [15]
    HASHMONAI M, CAMERON A E P, CONNERY C P, et al. The etiology of primary hyperhidrosis: a systematic review[J]. Clin Auton Res, 2017, 27(6): 379-383. doi: 10.1007/s10286-017-0456-0
    [16]
    LIN J B, KANG M Q, HUANG L P, et al. CHRNA1 promotes the pathogenesis of primary focal hyperhidrosis[J]. Mol Cell Neurosci, 2021, 111: 103598. DOI: 10.1016/j.mcn.2021.103598.
    [17]
    LIN J B, CHEN J F, LAI F C, et al. Involvement of activin a receptor type 1 (ACVR1) in the pathogenesis of primary focal hyperhidrosis[J]. Biochem Biophys Res Commun, 2020, 528(2): 299-304. doi: 10.1016/j.bbrc.2020.05.052
    [18]
    国家中医药管理局. 中医病证诊断疗效标准[S]. 南京: 南京大学出版社, 1994: 32-33.
    [19]
    李彩伟, 吴浩, 任保瑞, 等. 原发性手汗症患者社交回避及苦恼的现状分析[J]. 空军医学杂志, 2014, 30(2): 111-113.
    [20]
    王梦真, 罗玥, 刘子玉, 等. 从肝脾论治多汗症[J]. 北京中医药大学学报, 2024, 47(4): 490-495.
    [21]
    BARATEAU L, DIAB J, THOBOIS O, et al. Systematic assessment of dysexecutive syndrome, hypersomnolence and dysautonomia in kleine-levin syndrome[J]. Eur J Neurol, 2025, 32(7): e70259. DOI: 10.1111/ene.70259.
    [22]
    刘巍, 鲍霞, 王诗源. 手汗症中医经方辨治探讨[J]. 山东中医杂志, 2018, 37(10): 807-810.
    [23]
    李荣慧, 雷晓明, 张国民, 等. 张崇泉"二维四向法"治疗汗证经验[J]. 中华中医药杂志, 2022, 37(7): 3932-3935.
    [24]
    武广华, 臧益秀, 刘运祥, 等. 中国卫生管理辞典[M]. 北京: 中国科学技术出版社, 2001: 115.
    [25]
    张培玲, 李仙, 王晶晶. 原发性多汗症患者日常生活质量及心理体验的质性研究[J]. 当代护士, 2023, 30(5): 110-114.
    [26]
    PARASHAR K, ADLAM T, POTTS G. The impact of hyperhidrosis on quality of life: a review of the literature[J]. Am J Clin Dermatol, 2023, 24(2): 187-198. doi: 10.1007/s40257-022-00743-7
    [27]
    HENNING M A S, BOUAZZI D, JEMEC G B E. Treatment of hyperhidrosis: an update[J]. Am J Clin Dermatol, 2022, 23(5): 635-646. doi: 10.1007/s40257-022-00707-x
    [28]
    KAWAHARA K, SHIMOMURA Y, OSHIMA Y, et al. Case report: acquired generalized anhidrosis caused by brain tumor: review of the literature[J]. Front Endocrinol (Lausanne), 2022, 13: 877715. DOI: 10.3389/fendo.2022.877715.
    [29]
    BEHINAEIN P, GAVAGAN K, WAITZMAN J, et al. A review of the etiologies and key clinical features of secondary hyperhidrosis[J]. Am J Clin Dermatol, 2025, 26(1): 97-108. doi: 10.1007/s40257-024-00908-6
    [30]
    AUBIGNAT M. Hyperhidrosis from diagnosis to management[J]. Rev Med Interne, 2021, 42(5): 338-345. doi: 10.1016/j.revmed.2020.11.002
    [31]
    LÜTGERATH C, WEIß C, FAULHABER J, et al. Comparison of a novel aluminum lactate-based with an aluminum chloride-based antiperspirant in excessive axillary and inguinal perspiration: first randomized controlled trial[J]. J Dtsch Dermatol Ges, 2022, 20(12): 1589-1601.
    [32]
    NAWROCKI S, CHA J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options[J]. J Am Acad Dermatol, 2019, 81(3): 669-680. doi: 10.1016/j.jaad.2018.11.066
    [33]
    PATRA S, KAUR M, SHARMA V K. Stepwise treatment of primary focal hyperhidrosis with aluminum chloride hexahydrate lotion (20%) and oral glycopyrrolate: a retrospective study from a tertiary care center[J]. Dermatol Ther, 2020, 33(6): e13914. DOI: 10.1111/dth.13914.
    [34]
    ELKHOLY B M, ALI EBRAHIM S, OTHMAN SOBH M A, et al. A comparative study of aluminum chloride, oxybutynin chloride, and botulinum toxin in the treatment of primary focal hyperhidrosis[J]. J Cutan Med Surg, 2025, 21: 12034754251336233. DOI: 10.1177/12034754251336233.
    [35]
    GLASER D A, HEBERT A A, NAST A, et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials[J]. J Am Acad Dermatol, 2019, 80(1): 128-138. doi: 10.1016/j.jaad.2018.07.002
    [36]
    YOKOZEKI H, FUJIMOTO T, WANATABE S, et al. Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: a randomized, double-blind, vehicle-controlled study[J]. J Dermatol, 2022, 49(1): 86-94. doi: 10.1111/1346-8138.16188
    [37]
    ARTZI O, LOIZIDES C, ZUR E, et al. Topical oxybutynin 10% gel for the treatment of primary focal hyperhidrosis: a randomized double-blind placebo-controlled split area study[J]. Acta Derm Venereol, 2017, 97(9): 1120-1124. doi: 10.2340/00015555-2731
    [38]
    KIRSCH B, SMITH S, COHEN J, et al. Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: a phase II, randomized, controlled, double-blinded trial[J]. J Am Acad Dermatol, 2020, 82(6): 1321-1327. doi: 10.1016/j.jaad.2020.02.016
    [39]
    SCHOLLHAMMER M, BRENAUT E, MENARD-ANDIVOT N, et al. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial[J]. Br J Dermatol, 2015, 173(5): 1163-1168. doi: 10.1111/bjd.13973
    [40]
    CRUDDAS L, BAKER D M. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review[J]. J Eur Acad Dermatol Venereol, 2017, 31(6): 952-963. doi: 10.1111/jdv.14081
    [41]
    LIN Q, CAI B, CHEN L, et al. Contemporary algorithm for treating bromhidrosis: a review of treatment available[J]. Aesthetic Plast Surg, 2025, 49(13): 3841-3848. doi: 10.1007/s00266-024-04633-7
    [42]
    WATANABE H, OHSHIMA Y, WATANABE D. Therapeutic Effectiveness of needle injection versus needle-free jet injector system for botulinum toxin type a in palmar hyperhidrosis[J]. J Cutan Med Surg, 2023, 27(5): 481-486. doi: 10.1177/12034754231191062
    [43]
    LUEANGARUN S, SERMSILP C, TEMPARK T. Topical botulinum toxin type a liposomal cream for primary axillary hyperhidrosis: a double-blind, randomized, split-site, vehicle-controlled study[J]. Dermatol Surg, 2018, 44(8): 1094-1101. doi: 10.1097/DSS.0000000000001532
    [44]
    MALEK-KHATABI A, RAD-MALEKSHAHI M, SHAFIEI M, et al. Botulinum toxin A dissolving microneedles for hyperhidrosis treatment: design, formulation and in vivo evaluation[J]. Biomater Sci, 2023, 11(24): 7784-7804. doi: 10.1039/D3BM01301D
    [45]
    李祎铭, 李利. 腋窝多汗症诊断及A型肉毒毒素注射治疗专家共识[J]. 中国皮肤性病学杂志, 2024, 38(3): 237-242.
    [46]
    GALADARI H, GALADARI I, SMIT R, et al. Treatment approaches and outcomes associated with the use of abobotulinumtoxin A for the treatment of hyperhidrosis: a systematic review[J]. J Am Acad Dermatol, 2021, 85(5): 1121-1129. doi: 10.1016/j.jaad.2020.07.123
    [47]
    PRODAN-BARBULESCU C, CASTIGLIONE L, BURTIC S R, et al. Longitudinal assessment of facial hyperhidrosis management: evaluating the utility and quality of life improvements following botulinum toxin injection[J]. Toxins (Basel), 2024, 16(1): 59. DOI: 10.3390/toxins16010059.
    [48]
    CAMPANATI A, DIOTALLEVI F, RADI G, et al. Efficacy and safety of botulinum toxin B in focal hyperhidrosis: a narrative review[J]. Toxins (Basel), 2023, 15(2): 147. DOI: 10.3390/toxins15020147.
    [49]
    SUN J, CHEN S, YANG T, et al. Efficacy and safety of botulinum toxin type A in primary axillary hyperhidrosis: a meta-analysis and systematic review[J]. Aesthetic Plast Surg, 2025, 49(17): 4932-4940. doi: 10.1007/s00266-025-04909-6
    [50]
    WALLING H W. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine[J]. J Am Acad Dermatol, 2012, 66(3): 387-392. doi: 10.1016/j.jaad.2011.01.023
    [51]
    张伯礼, 吴勉华. 中医内科学[M]. 北京: 中国中医院出版社, 2017: 331.
    [52]
    李倩, 老锦雄. 《针灸大成》论治汗证探微[J]. 浙江中医杂志, 2023, 58(2): 137-138.
    [53]
    田纪良, 胡泉. 中医药治疗多汗症的研究进展[J]. 内蒙古中医药, 2024, 43(4): 164-166.
    [54]
    田湘平, 吴剑芳, 陈可. 黄芪建中汤加减联合五倍子散外敷神阙穴治疗小儿汗证的效果分析[J]. 医学理论与实践, 2024, 37(16): 2788-2790.
    [55]
    夏宁俊, 顾根网, 陈艳, 等. 固表扶正止瘤汗汤联合益气敛汗散治疗气血两虚型肿瘤相关性汗证疗效观察[J]. 广西中医药大学学报, 2025, 28(4): 20-24.
    [56]
    RAHIM M, AHMED N, NAZ KHAN K, et al. Comparison of the efficacy of tap water iontophoresis versus aluminum chloride hexahydrate in the treatment of palmoplantar hyperhidrosis[J]. Cureus, 2022, 14(12): e32367. DOI: 10.7759/cureus.32367.
    [57]
    HOSSEINI S M, GHANDALI E, MOGHIMI H R, et al. A comparative evaluation of aluminum chloride hexahydrate gel iontophoresis versus tap water iontophoresis in people with primary palmar hyperhidrosis: a randomised clinical trial[J]. Indian J Dermatol Venereol Leprol, 2023, 90(1): 52-58.
    [58]
    HÖLZLE E. Tap water iontophoresis[J]. Hautarzt, 2012, 63(6): 462-468. doi: 10.1007/s00105-012-2332-0
    [59]
    GLASER D A, COLEMAN W P, FAN L K, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study[J]. Dermatol Surg, 2012, 38(2): 185-191.
    [60]
    GUPTA A K, VENKATARAMAN M, JOSHI L T, et al. Potential use of microwave technology in dermatology[J]. J Dermatolog Treat, 2022, 33(7): 2899-2910. doi: 10.1080/09546634.2022.2089333
    [61]
    PISSA M, HASHEM R, SHAYESTEH A, et al. Evaluation of quality of life, anxiety, and depression in patients with primary axillary hyperhidrosis undergoing treatment with a microwave device: one-year follow-up[J]. Acta Derm Venereol, 2024, 104: adv40543. DOI: 10.2340/actadv.v104.40543.
    [62]
    JUNG J M, NA H M, KIM J H, et al. The efficacy and safety of a fractional microneedle radiofrequency device for the treatment of axillary hyperhidrosis: clinical prospective pilot study[J]. Lasers Med Sci, 2022, 37(3): 1559-1566. doi: 10.1007/s10103-021-03404-z
    [63]
    TAUDORF E H, HENNING M, OLSEN J, et al. Attempted treatment of primary axillary hyperhidrosis with one session of either neodymium YAG laser or intense pulsed light: a within patient randomized trial of treated versus untreated contralateral axilla[J]. Lasers Surg Med, 2023, 55(8): 748-757. doi: 10.1002/lsm.23697
    [64]
    林清财, 林剑波, 涂远荣, 等. 243例原发性手汗症患者胸腔镜下胸交感神经切断术后生活质量分析[J]. 中国胸心血管外科临床杂志, 2022, 29(3): 294-300.
    [65]
    陈安平, 龚明, 黎兰, 等. 日间快速康复模式下胸腔镜交感神经切断术治疗手汗症的单中心回顾性队列研究[J]. 中国胸心血管外科临床杂志, 2022, 29(3): 301-305.
    [66]
    UREÑA A, GRANDO L, RODRIGUEZ-GUSSINYER L, et al. 20-year efficacy of endoscopic thoracic sympathectomy for primary hyperhidrosis: a cohort study[J]. J Clin Med, 2025, 14(14): 4831. DOI: 10.3390/jcm14144831.
    [67]
    LIMA S O, NETO J M, FONTES L M, et al. Evaluation of quality of life (QOL) of young patients with primary hyperhidrosis (PH) before and after endoscopic thoracic sympathectomy (ETS)[J]. J Am Acad Dermatol, 2023, 88(5): e197-e201. doi: 10.1016/j.jaad.2015.10.048
    [68]
    TOOLABI K, PARSAEI R, FARID R, et al. Endoscopic thoracic sympathotomy for primary hyperhidrosis: predictors of outcome over a 10-year period[J]. Surg Endosc, 2022, 36(5): 3585-3591. doi: 10.1007/s00464-021-08684-8
    [69]
    陈曦, 唐旭, 甘佳伟, 等. 个人与家庭自我管理理论在护理实践中的应用及研究进展[J]. 中华现代护理杂志, 2024, 30(32): 4465-4469.
    [70]
    吴梦雅, 王杰, 回恬静, 等. 慢性病健康管理模式的研究进展[J]. 中国健康教育, 2025, 41(9): 828-832, 843.
    [71]
    林雪霏, 吴楠, 张海萍. 多汗症患者焦虑抑郁状态及睡眠情况研究[J]. 首都医科大学学报, 2021, 42(5): 841-846.
    [72]
    雷旭光, 戴骊颖, 于炳洋, 等. A型肉毒毒素治疗手部多汗症的效果[J]. 中华医学美学美容杂志, 2023, 29(3): 227-230.
    [73]
    KISIELNICKA A, SZCZERKOWSKA-DOBOSZ A, PURZYCKA-BOHDAN D, et al. Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities[J]. Postepy Dermatol Alergol, 2022, 39(2): 251-257. doi: 10.5114/ada.2022.115887
    [74]
    HU Y, CONVERSE C, LYONS M C, et al. Neural control of sweat secretion: a review[J]. Br J Dermatol, 2018, 178(6): 1246-1256. doi: 10.1111/bjd.15808
    [75]
    DE MOURA JÚNIOR N B, DAS-NEVES-PEREIRA J C, DE OLIVEIRA F R, et al. Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis[J]. Ann Thorac Surg, 2013, 95(2): 465-470. doi: 10.1016/j.athoracsur.2012.10.068
    [76]
    HENNING M A S, JEMEC G B E, PEDERSEN O B, et al. Cluster analysis identifies clinical phenotypes of primary hyperhidrosis[J]. Skin Pharmacol Physiol, 2024, 37(4-6): 63-69.
    [77]
    JEONG S C, KIM J J, KIM Y H, et al. Heart rate variability as a potential diagnostic tool to predict compensatory hyperhidrosis after sympathectomy in patients with primary focal hyperhidrosis[J]. J Thorac Dis, 2020, 12(11): 6789-6796. doi: 10.21037/jtd-20-2038
    [78]
    KARACA S, KULAC M, UZ E, et al. Erythrocyte oxidant/antioxidant status in essential hyperhidrosis[J]. Mol Cell Biochem, 2006, 290(1-2): 131-135. doi: 10.1007/s11010-006-9177-8
    [79]
    AKBAŞ A, KILINÇ F. Can thiol-disulfide balance be an indicator of oxidative stress for hyperhidrosis?[J]. J Cosmet Dermatol, 2022, 21(7): 3031-3037. doi: 10.1111/jocd.14533
    [80]
    HENNING M A S, THORLACIUS L, IBLER K S, et al. How to diagnose and measure primary hyperhidrosis: a systematic review of the literature[J]. Clin Auton Res, 2021, 31(4): 511-528. doi: 10.1007/s10286-021-00794-6
    [81]
    MANAV V, TVRK C B, KARA POLAT A, et al. Evaluation of the serum magnesium and vitamin D levels and the risk of anxiety in primary hyperhidrosis[J]. J Cosmet Dermatol, 2022, 21(1): 373-379. doi: 10.1111/jocd.14075
    [82]
    GROVE G L, JACOBSEN K, MAARTENSSON N L, et al. Subclinical effects of botulinum toxin A and microwave thermolysis for axillary hyperhidrosis: a descriptive study with line-field confocal optical coherence tomography and histology[J]. Exp Dermatol, 2024, 33(6): e15110. DOI: 10.1111/exd.15110.
    [83]
    OGIEN J, TAVERNIER C, FISCHMAN S, et al. Dubois A. Line-field confocal optical coherence tomography (LC-OCT): principles and practical use[J]. Ital J Dermatol Venerol, 2023, 158(3): 171-179.
    [84]
    ZHOU Z, JIN D, HE J, et al. Digital health platform for improving the effect of the active health management of chronic diseases in the community: mixed methods exploratory study[J]. J Med Internet Res, 2024, 26: e50959. DOI: 10.2196/50959.
    [85]
    TIGHE S A, BALL K, KENSING F, et al. Toward a digital platform for the self-management of noncommunicable disease: systematic review of platform-like interventions[J]. J Med Internet Res, 2020, 22(10): e16774. DOI: 10.2196/16774.
    [86]
    GROVE G L, TOGSVERD-BO K, SCHWENSEN J F B, et al. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis[J]. Lasers Surg Med, 2023, 55(1): 105-115. doi: 10.1002/lsm.23610
    [87]
    GABES M, KNVTTEL H, APFELBACHER C J. Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review[J]. Syst Rev, 2021, 10(1): 163. DOI: 10.1186/s13643-021-01701-w.
    [88]
    OGAWA S, TAYAMA J, MUROTA H, et al. The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms[J]. Biopsychosoc Med, 2024, 18(1): 14. DOI: 10.1186/s13030-024-00310-y.
    [89]
    KLEIN S Z, HULL M, GILLARD K K, et al. Treatment patterns, depression, and anxiety among US patients diagnosed with hyperhidrosis: a retrospective cohort study[J]. Dermatol Ther (Heidelb), 2020, 10(6): 1299-1314. doi: 10.1007/s13555-020-00439-y
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(8)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (45) PDF downloads(18) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return